GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a truly shift in how we handle type 2 diabetes . These new therapies function to stimulating the body’s own GLP-1 substance , https://antonrojj157372.yomoblog.com/49331090/glp-1-a-revolutionary-breakthrough-in-glucose-care